Left ventricular assist devices (LVAD) have revolutionized the management of advanced
heart failure. However, complications rates remain high, among which hemorrhagic and …

Life expectancy of patients with a durable, continuous-flow left ventricular assist device (CF-
LVAD) continues to increase. Despite significant improvements in the delivery of care for …

Left ventricular assist device (LVAD) use has revolutionised the care of patients with
advanced heart failure, allowing more patients to survive until heart transplantation and …

Background Intracranial hemorrhage (ICH) has been reported to occur in up to 23% of
patients with left ventricular assist devices (LVADs). Currently, limited data exists to guide …

Background Anticoagulation therapy with warfarin is common before heart transplantation
and complicates perioperative management. Methods This single-center, noninterventional …

Background There is a dearth of literature regarding management and outcomes of patients
with a left ventricular assist device (LVAD) for advanced heart failure who develop …

OBJECTIVE As the use of left ventricular assist devices (LVADs) has expanded,
cerebrovascular complications have become an increasing source of morbidity and mortality …

Background Intracranial hemorrhage (ICH) is a common complication in patients with left
ventricular assist devices (LVADs) and carries a dismal prognosis. Limited data are …

Objectives Management of left ventricular assist device (LVAD)-associated intracranial
hemorrhage (ICH) is complicated by the competing concerns of hematoma expansion and …

Durable left ventricular assist device (LVAD) recipients require long-term anticoagulation to
prevent thromboembolic complications. Their management is complicated by the risk of …